Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Obesity is associated with an increased risk of cardiovascular disease. C1q/TNF-related protein (CTRP)-1 is a poorly characterized adipokine that is up-regulated in association with ischemic heart disease. We investigated the role of
CTRP1
in myocardial ischemia injury.
CTRP1
-knockout mice showed increased myocardial infarct size, cardiomyocyte apoptosis, and proinflammatory gene expression after I/R compared with wild-type (WT) mice. In contrast, systemic delivery of
CTRP1
attenuated myocardial damage after I/R in WT mice. Treatment of cardiomyocytes with
CTRP1
led to reduction of hypoxia-reoxygenation-induced apoptosis and
lipopolysaccharide
-stimulated expression of proinflammatory cytokines, which was reversed by inhibition of sphingosine-1-phosphate (S1P) signaling. Treatment of cardiomyocytes with
CTRP1
also resulted in the increased production of cAMP, which was blocked by suppression of S1P signaling. The antiapoptotic and anti-inflammatory actions of
CTRP1
were cancelled by inhibition of adenylyl cyclase or knockdown of adiponectin receptor 1. Furthermore, blockade of S1P signaling reversed
CTRP1
-mediated inhibition of myocardial infarct size, apoptosis, and inflammation after I/R in vivo. These data indicate that
CTRP1
protects against myocardial ischemic injury by reducing apoptosis and inflammatory response through activation of the S1P/cAMP signaling pathways in cardiomyocytes, suggesting that
CTRP1
plays a crucial role in the pathogenesis of ischemic heart disease.
...
PMID:C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart. 2657 87